cgp 39551 has been researched along with Body Weight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciani, E; Contestabile, A; Dall'Olio, R; Facchinetti, F; Fonnum, F; Virgili, M | 1 |
Contestabile, A; Dall'Olio, R; Facchinetti, F; Gandolfi, O; Lucchi, R; Sparapani, M; Tregnago, M; Virgili, M | 1 |
2 other study(ies) available for cgp 39551 and Body Weight
Article | Year |
---|---|
Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Choline O-Acetyltransferase; Dizocilpine Maleate; Female; Motor Activity; Pregnancy; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1993 |
Neuronal nitric oxide synthase is permanently decreased in the cerebellum of rats subjected to chronic neonatal blockade of N-methyl-D-aspartate receptors.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Benzamides; Body Weight; Cerebellum; Depression, Chemical; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Hyperkinesis; Immunohistochemistry; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time | 1998 |